A password will be e-mailed to you.

Trigger For Autoimmune Disease Identified

Summary: Researchers have discovered a possible trigger for autoimmune diseases such as lupus, Crohn’s disease and MS. Findings may explain how women are more susceptible to autoimmune disorders than men.

Source: National Jewish Health.

Newly identified cells help explain why women suffer autoimmune disease more often.

Researchers at National Jewish Health have identified a trigger for autoimmune diseases such as lupus, Crohn’s disease and multiple sclerosis. The findings, published in the April 2017 issue of Journal of Clinical Investigation, help explain why women suffer autoimmune disease more frequently than men, and suggest a therapeutic target to prevent autoimmune disease in humans.

“Our findings confirm that Age-associated B Cells (ABCs) drive autoimmune disease,” said Kira Rubtsova, PhD, an instructor in biomedical science at National Jewish Health. “We demonstrated that the transcription factor T-bet inside B cells causes ABCs to develop. When we deleted T-bet inside B cells, mice prone to develop autoimmune disease remained healthy. We believe the same process occurs in humans with autoimmune disease, more often in elderly women.”

Autoimmune diseases occur when the immune system attacks and destroys the organs and tissue of its own host. Dozens of autoimmune diseases afflict millions of people in the United States. Several autoimmune diseases, including lupus, rheumatoid arthritis and multiple sclerosis strike women two to 10 times as often as men. Overall, about 80 percent of autoimmune patients are women. There is no cure for autoimmune disease.

B cells are important players in autoimmune disease. The National Jewish Health research team, led by Chair of Biomedical Science Philippa Marrack, PhD, previously identified a subset of B cells that accumulate in autoimmune patients, autoimmune and elderly female mice. They named the cells Age-associated B cells, or ABCs. Subsequent research showed that the transcription factor T-bet plays a crucial role in the appearance of ABC.

Image shows a DNA strand.

Transcription factors bind to DNA inside cells and drive the expression of one or several genes. Researchers believe that T-bet appears inside cells when a combination of receptors on B-cell surfaces — TLR7, Interferon-gamma and the B-cell receptor — are stimulated. NeuroscienceNews.com image is for illustrative purposes only.

Transcription factors bind to DNA inside cells and drive the expression of one or several genes. Researchers believe that T-bet appears inside cells when a combination of receptors on B-cell surfaces — TLR7, Interferon-gamma and the B-cell receptor — are stimulated.

Through breeding and genetic techniques the research team eliminated the ability of autoimmune-prone mice to express T-bet inside their B cells. As a result, ABCs did not appear and the mice remained healthy. Kidney damage appeared in 80 percent of mice with T-bet in the B cells and in only 20 percent of T-bet-deficient mice. Seventy-five percent of mice with T-bet in their B cells died by 12 months, while 90 percent of T-bet-deficient mice survived 12 months.

“Our findings for the first time show that ABCs are not only associated with autoimmune disease, but actually drive it,” said Dr. Rubtsova.

ABCs have attracted increasing interests since their discovery in 2011. Dr. Rubtsova and her colleagues at National Jewish Health have expanded their study of ABCs beyond autoimmune disease and are looking at their involvement in sarcoidosis, hypersensitivity pneumonitis and chronic beryllium disease.

About this neuroscience research article

Funding: Funding provided by US Public Health Service, National Institutes of Health.

Source: William Allstetter – National Jewish Health
Image Source: NeuroscienceNews.com image is in the public domain.
Original Research: Full open access research for “B cells expressing the transcription factor T-bet drive lupus-like autoimmunity” by Kira Rubtsova, Anatoly V. Rubtsov, Joshua M. Thurman, Johanna M. Mennona, John W. Kappler, and Philippa Marrack in Journal of Clinical Investigation. Published online February 27 2017 doi:10.1172/JCI91250

Cite This NeuroscienceNews.com Article
National Jewish Health “Trigger For Autoimmune Disease Identified.” NeuroscienceNews. NeuroscienceNews, 10 May 2017.
<http://neurosciencenews.com/autoimmune-disease-triggers-6641/>.
National Jewish Health (2017, May 10). Trigger For Autoimmune Disease Identified. NeuroscienceNew. Retrieved May 10, 2017 from http://neurosciencenews.com/autoimmune-disease-triggers-6641/
National Jewish Health “Trigger For Autoimmune Disease Identified.” http://neurosciencenews.com/autoimmune-disease-triggers-6641/ (accessed May 10, 2017).

Abstract

B cells expressing the transcription factor T-bet drive lupus-like autoimmunity

B cells contribute to multiple aspects of autoimmune disorders and may play a role in triggering disease. Thus, targeting B cells may be a promising strategy for treating autoimmune disorders. Better understanding of the B cell subsets that are responsible for the development of autoimmunity will be critical for developing efficient therapies. Here we have reported that B cells expressing the transcription factor T-bet promote the rapid appearance of autoantibodies and germinal centers in spontaneous murine models of systemic lupus erythematosus (SLE). Conditional deletion of T-bet from B cells impaired the formation of germinal centers and mitigated the development of kidney damage and rapid mortality in SLE mice. B cell–specific deletion of T-bet was also associated with lower activation of both B cells and T cells. Taken together, our results suggest that targeting T-bet–expressing B cells may be a potential target for therapy for autoimmune diseases.

“B cells expressing the transcription factor T-bet drive lupus-like autoimmunity” by Kira Rubtsova, Anatoly V. Rubtsov, Joshua M. Thurman, Johanna M. Mennona, John W. Kappler, and Philippa Marrack in Journal of Clinical Investigation. Published online February 27 2017 doi:10.1172/JCI91250

Feel free to share this Neuroscience News.
No more articles